Avantor, Inc. is a healthcare company.
Avantor, Inc. (AVTR) is expected to report earnings on Wednesday, November 4, 2026, before the open. Estimated release time 06:13 ET. Consensus EPS estimate is $0.21.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | FY2026 Q2 | $0.19 | $0.21 | +9.7% | $1.69B |
| 2026-04-29 | FY2026 Q1 | $0.16 | $0.17 | +8.3% | $1.58B |
| 2026-02-11 | FY2025 Q4 | $0.21 | $0.22 | +4.8% | $1.66B |
| 2025-10-29 | FY2025 Q3 | $0.22 | $0.22 | -2.1% | $1.62B |
| 2025-08-01 | FY2025 Q2 | $0.25 | $0.24 | -4.0% | $1.68B |
| 2025-04-25 | FY2025 Q1 | $0.23 | $0.23 | -0.6% | $1.58B |
| 2025-02-07 | FY2024 Q4 | $0.25 | $0.74 | +196.0% | $1.69B |
| 2024-10-25 | FY2024 Q3 | $0.25 | $0.26 | +2.1% | $1.71B |
AVTR has beaten consensus EPS in 5 of its last 8 reported quarters.
AVTR reported Jul 29. The highlights: EPS of $0.21 — a beat vs the $0.19 estimate (+10%); revenue of $1.69B — a beat vs the $1.61B consensus (+5%).
See AVTR on the live calendar →